NCT00083551 · OUTCOME

Overall Survival

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy · Source last updated 2015-11-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: percentage of participants
Interval / dispersion: Not reported
Time frame: 6 Years

What was measured

Overall Survival at six years after initiating protocol therapy

Groups in this outcome

Thalidomide

Thalidomide 400 QD during induction, 100 mg QD between transplants, 200 mg QD post transplant, 100 mg QD during year one of maintenance, and 50 mg QD during second year of maintenance.

No Thalidomide

Patient received no thalidomide during induction, consolidation, and maintenance therapy.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Thalidomide	323
No Thalidomide	345

Reported measurements

Source class 1

Values in percentage of participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Thalidomide	65	Not reported	Not reported	Not reported	Not reported
No Thalidomide	58	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
65
group Id
OG001
value
58

denoms

counts
group Id
OG000
value
323
group Id
OG001
value
345
units
Participants

description

Overall Survival at six years after initiating protocol therapy

groups

description
Thalidomide 400 QD during induction, 100 mg QD between transplants, 200 mg QD post transplant, 100 mg QD during year one of maintenance, and 50 mg QD during second year of maintenance.
id
OG000
title
Thalidomide
description
Patient received no thalidomide during induction, consolidation, and maintenance therapy.
id
OG001
title
No Thalidomide

param Type

NUMBER

reporting Status

POSTED

time Frame

6 Years

title

Overall Survival

type

PRIMARY

unit Of Measure

percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice